Episode Details

Back to Episodes
Episode 398: Journal Club Including Fluorescein Angiography Cost, Biosimilar Effect on Health Care System Cost, Practice Consolidation in Ophthalmology, Physician Turnover in Ophthalmology

Episode 398: Journal Club Including Fluorescein Angiography Cost, Biosimilar Effect on Health Care System Cost, Practice Consolidation in Ophthalmology, Physician Turnover in Ophthalmology

Published 2 years, 10 months ago
Description

Drs. Safa Rahmani, Akshay Thomas, and Priya Vakharia join to discuss four recent publications in major ophthalmology journals.

Fluorescein Angiography Cost (https://ophthalmologyretina.org/article/S2468-6530(23)00227-0/fulltext)

Intravitreal Biosimilar Cost Impact (https://www.aaojournal.org/article/S0161-6420(23)00295-6/fulltext)

Practice Consolidation in Ophthalmology (https://www.aaojournal.org/article/S0161-6420(23)00311-1/fulltext)

Physician Turnover in Ophthalmology (https://www.aaojournal.org/article/S0161-6420(23)00308-1/fulltext)


Relevant Financial Disclosures: Dr. Rahmani is an investigator for Regeneron. Dr. Thomas is a consultant for Allergan and Novartis. Dr. Vakharia is a consultant for Genentech and Regeneron. Dr. Sridhar is a consultant for Genentech and Regeneron.

You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us